生物标志物 生物标志物
Lieke Bakker1,2,3, Sebastian Köhler1,2,3, Kyonghwan Choe2,3
1Alzheimer Center Limburg, Maastricht University, Maastricht, Limburg, Netherlands.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
在中风后,托-金氨酸通路似乎失调,无论认知障碍如何. 这项研究调查了跨越认知衰退阶段的kynurenine和B族维生素水平.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 代谢学 代谢学 代谢学
背景情况:
- 托-金林通路与神经退行性和脑血管疾病的认知衰退有关.
- 之前对金氨酸的临床研究规模和范围有限,特别是在前发性疾病阶段.
- 需要一种跨诊断方法来调查在痴呆和认知障碍阶段的金氨酸和B族维生素水平.
研究的目的:
- 为了研究托芬,金氨酸代谢物和B族维生素的血水平.
- 将这些水平在认知衰退的不同诊断阶段进行比较,包括健康对照组,主观认知衰退 (SCD),轻度认知障碍 (MCI),痴呆症和中风后认知障碍 (PSCI/PSNCI).
- 探索托-金林通路在认知衰退和脑血管疾病中的作用.
主要方法:
- 分析了来自2,452名健康老年人和759名认知障碍或中风后疾病患者的血样本.
- 使用液体染色学-并联质谱法 (LC-MS/MS) 量化托芬,七种kynurenine代谢物和两种B族维生素.
- 进行了线性回归分析,以评估群体之间的差异,并对混因素进行调整. 代谢物经过日志转换并标准化以进行比较.
主要成果:
- 与对照人群相比,中风患者的血水平显著降低了托,桑氨酸,氧化5'-酸, рибофлавин,以及氨酸与氨酸的比率.
- 相反,中风患者的金氨酸,3-氧金氨酸,3-氧氨酸,氨酸和金氨酸与酸的比率较高.
- 这些变化在患有中风后认知障碍 (PSCI) 和没有中风后认知障碍 (PSNCI) 的患者中观察到,这些小组之间没有显著差异.
结论:
- 初步发现表明,中风后的金氨酸途径的调节失调,独立于认知障碍.
- 需要进一步的研究来验证这些观察,并阐明涉及到的精确机制.
- 这项研究强调了向金氨酸途径在管理与脑血管事件相关的认知缺陷方面的潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516